Document is current
Any future updates will be listed below
-
Authors
Suber, Tomeka L.
Tabary, Mohammadreza
Bain, William
Olonisakin, Tolani
Lockwood, Karina
Xiong, Zeyu
Zhang, Yingze
Kohli, Naina
Furguiele, Lauren
Peñaloza, Hernán
McVerry, Bryan J.
Rose, Jason J.
Shah, Faraaz
Methé, Barbara
Li, Kelvin
Mallampalli, Rama K.
Chen, Kong
Fan, Li
Morris, Alison
Tyurin, Vladimir A.
Samovich, Svetlana N.
Bayir, Hülya
Tyurina, Yulia Y.
Kagan, Valerian
Lee, Janet S.
-
Funding
Funding for this research was provided by:
National Institutes of Health (P01HL114453)
- License Information
-
More Information
Article History
Received: 16 April 2024
Accepted: 11 November 2024
First Online: 30 December 2024
Declarations
:
: JJR is a cofounder of Omnibus Medical Devices and a shareholder, officer, and director of Globin Solutions, outside of the submitted work. JJR is a coinventor on patents and applications related to using carbon monoxide scavenging molecules as therapies for carbon monoxide poisoning, licensed to Globin Solutions. Globin Solutions has a license for technologies using nitrite as a therapy against cardiovascular disease from the National Institutes of Health and the University of Pittsburgh. JJR is a coinventor on a patent using nitrite as a treatment for chemical and smoke inhalational injuries. BJM receives grant funding from Genentech and has received consulting fees from Synairgen Research, Ltd., BioAegis, and Boehringer Ingelheim. All other authors declare no competing interests.
